Myelitis - 118 Studies Found

Completed : Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
:
  • Acute Disseminated Encephalomyelitis
  • Devic's Syndrome
  • : 2000-02-24
    : Procedure: Plasma exchange
Active, not recruiting : Biobank For MS And Other Demyelinating Diseases
:
  • Multiple Sclerosis
  • Transverse Myelitis
  • Neuromyelitis Optic
    : 2007-03-08
Enrolling by invitation : Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine
: Venezuelan Equine Encephalomyelitis
: 2007-12-19
: Biological: VEE TC-83 Subjects will receive a single 0.5 mL dose by subcutaneous route in the upper oute
Completed : Oral Melatonin Plus Zinc Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)
:
  • Fatigue Syndrome, Chronic
  • Myalgic Encephalomyelitis

: 2016-12-19
:
  • Dietary Supplement: melatonin plus zinc

Completed : The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome
:
  • Chronic Fatigue Syndrome
  • Myalgic Encephalomyelitis

: 2005-09-16
: Drug: Ampligen
Terminated : Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
:
  • Chronic Fatigue Syndrome
  • Myalgic Encephalomyelitis

: 2012-11-08
: Drug: Etanercept Weekly subcutaneous injections of Etanercept 50 mg, for up to 12 months.
Completed : Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
:
  • Chronic Fatigue Syndrome
  • Myalgic Encephalomyelitis
  • : 2016-07-29
    :
    • Drug: Normal Saline 1 liter of
Completed : Myalgic Encephalomyelitis Chronic Fatigue at the National Institutes of Health
: Chronic Fatigue Syndrome
: 2016-01-29
Terminated : B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome
:
  • Chronic Fatigue Syndrome
  • Myalgic Encephalomyelitis

: 2010-07-02
: Drug: Rituximab Two infusions of Rituximab 500 mg/m2 (max
Completed : B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome
:
  • Chronic Fatigue Syndrome
  • Myalgic Encephalomyelitis

: 2010-07-02
: Drug: Rituximab Two infusions of Rituximab 500 mg/m2 (max
Next >>>